Jove
Visualize
Contact Us

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

573
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
573
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

494
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
494
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

1.7K
The pathophysiology of pneumonia involves the following steps:
1.7K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

360
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
360
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

580
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of intraoperative use of 20% albumin in combination with Ringer's lactate versus Ringer's lactate during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: protocol for a randomised controlled, open-label clinical trial (ALBUCHIP trial).

BMJ open·2026
Same author

Intraoperative Hemodynamic Management during Liver Transplantation and Postoperative Morbidity: A Multicenter Cohort Study.

Anesthesiology·2026
Same author

Preparedness and performance in pediatric assessment: linking OSCE, written exams, and training exposure in a two-year comparative study of medical students.

BMC medical education·2026
Same author

Invasive aspergillosis in liver transplant recipients in France (2007-21): a nationwide, retrospective, matched case-control study.

The Lancet. Microbe·2026
Same author

Deep white matter MRI predicts outcomes in coma of various etiologies: a cohort study.

Critical care (London, England)·2026
Same author

Non-Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007-2021.

Medical mycology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 16, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.2K

Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized

Antoine Monsel1, Antoni Torres2, Yinggang Zhu3

  • 1Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, Sorbonne University of Paris, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.

Current Opinion in Infectious Diseases
|February 19, 2021
PubMed
Summary

Future trials on nebulized antibiotics for ventilator-associated pneumonia (VAP) require specific methods. Studies should focus on extensively drug-resistant Gram-negative bacteria (GNB) and optimize delivery for better lung penetration.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

673

Related Experiment Videos

Last Updated: Nov 16, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.2K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.9K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

673

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Nebulized antibiotics show promise for ventilator-associated pneumonia (VAP).
  • Recent trials found no benefit for Gram-negative bacteria (GNB) VAP.
  • Methodological improvements are needed for future research.

Purpose of the Study:

  • To review methodological requirements for future randomized controlled trials (RCTs) on nebulized antibiotics in VAP.
  • To address the failure of recent RCTs to demonstrate benefit in GNB-VAP.

Main Methods:

  • Analysis of factors influencing antibiotic lung deposition.
  • Review of nebulizer technologies (mesh vs. jet, breath-synchronized).
  • Discussion of optimal ventilator settings and sedation requirements.
  • Proposal for future RCT design, including drug choice, dosage, duration, and patient selection criteria.

Main Results:

  • High antibiotic doses are necessary for lung parenchyma penetration.
  • Mesh nebulizers outperform jet nebulizers; breath-synchronized systems are insufficient for high doses.
  • Epithelial lining fluid concentrations may not represent interstitial lung concentrations.
  • Sedation is required for ventilator synchrony to optimize lung deposition.

Conclusions:

  • Future RCTs should investigate nebulized amikacin or colistimethate sodium (CMS) for 3-5 days.
  • Trials must target VAP/ventilator-associated tracheobronchitis caused by extensively drug-resistant or pandrug-resistant GNB.
  • Specific dosages and comparisons with intravenous therapies are proposed for amikacin and CMS.